Lymphoplasmacytic lymphoma: Difference between revisions

From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
No edit summary
 
Line 1: Line 1:
 
== Definition ==
 
== Definition ==
   
* Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called Waldenstrom's macroglobulinemia)
+
* Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called [[Waldenström macroglobulinemia]])
   
 
== Investigations ==
 
== Investigations ==
Line 10: Line 10:
   
 
* Hyperviscosity, including neurological symptoms
 
* Hyperviscosity, including neurological symptoms
* Peripheral neuropathy
+
* [[Peripheral neuropathy]]
 
* Lymphadenopathy, organomegaly, cytopenia
 
* Lymphadenopathy, organomegaly, cytopenia
 
* Constitutional symptoms
 
* Constitutional symptoms
Line 19: Line 19:
 
* Treatment only indicated if symptoms progressing
 
* Treatment only indicated if symptoms progressing
 
* From most to least effective (and most to least side effects):
 
* From most to least effective (and most to least side effects):
** RCP: rituximab, cyclophosphamide, prednisone (or dexamethasone for DRC)
+
** [[RCP]]: [[rituximab]], [[cyclophosphamide]], [[prednisone]] (or [[dexamethasone]] for [[DRC]])
** BR: bendamustine/rituximab
+
** [[BR]]: [[bendamustine]]/[[rituximab]]
** Chlorambucil/Obinutuzumab
+
** [[Chlorambucil]]/[[Obinutuzumab]]
** Ibrutinib
+
** [[Ibrutinib]]
* Before chemotherapy, screen for hepatitis B +/- TB/Strongy
+
* Before chemotherapy, screen for [[hepatitis B]] +/- [[TB]]/[[Strongyloides]]
   
 
[[Category:Hematology]]
 
[[Category:Hematology]]

Latest revision as of 14:03, 26 July 2023

Definition

Investigations

  • SPEP and immunofixation showing IgM-kappa M-protein

Clinical Manifestations

  • Hyperviscosity, including neurological symptoms
  • Peripheral neuropathy
  • Lymphadenopathy, organomegaly, cytopenia
  • Constitutional symptoms

Management